• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Tekmira Pharmaceuticals Corp

+ Add to Watchlist

TKM:CN

21.4000 CAD 0.4700 2.25%

As of 15:28:07 ET on 08/27/2014.

Snapshot for Tekmira Pharmaceuticals Corp (TKM)

Open: 20.8300 Day's Range: 20.1800 - 22.0200 Volume: 310,254
Previous Close: 20.9300 52wk Range: 5.2600 - 34.6600 1-Yr Rtn: +297.76%

Stock Chart for TKM

No chart data available.
  • TKM:CN 21.4000
  • 1D
  • 1M
  • 1Y
20.9300
Interactive TKM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TKM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (USD) (ttm) -1.7163
Est. EPS (USD) (12/2014) -1.4980
Est. PEG Ratio -
Market Cap (M CAD) 473.29
Shares Outstanding (M) 22.11
30 Day Average Volume 407,445
Price/Book (mrq) 4.1273
Price/Sale (ttm) 21.2408
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TKM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TKM

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company. The Company is focused on advancing RNAi therapeutics and providing its lipid nanoparticle delivery technology to its pharmaceutical partners.

Mark J MurrayPresident/CEOBruce CousinsExec VP:Finance/CFO
Ian MaclachlanExec VP/Chief Technical OfficerMichael J AbramsExec VP/Chief Discovery Officer
More Company Profile & Key Executives for TKM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil